Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Zai Lab (ZLAB) EBT Margin (2018 - 2025)

Historic EBT Margin for Zai Lab (ZLAB) over the last 7 years, with Q3 2025 value amounting to 30.98%.

  • Zai Lab's EBT Margin rose 97700.0% to 30.98% in Q3 2025 from the same period last year, while for Sep 2025 it was 46.83%, marking a year-over-year increase of 293100.0%. This contributed to the annual value of 64.44% for FY2024, which is 610200.0% up from last year.
  • Zai Lab's EBT Margin amounted to 30.98% in Q3 2025, which was up 97700.0% from 37.03% recorded in Q2 2025.
  • Over the past 5 years, Zai Lab's EBT Margin peaked at 30.98% during Q3 2025, and registered a low of 1159.55% during Q1 2021.
  • Its 5-year average for EBT Margin is 211.27%, with a median of 99.89% in 2023.
  • In the last 5 years, Zai Lab's EBT Margin plummeted by -5772800bps in 2021 and then surged by 9836800bps in 2022.
  • Zai Lab's EBT Margin (Quarter) stood at 480.66% in 2021, then surged by 79bps to 98.67% in 2022, then plummeted by -47bps to 144.96% in 2023, then skyrocketed by 48bps to 74.89% in 2024, then soared by 59bps to 30.98% in 2025.
  • Its last three reported values are 30.98% in Q3 2025, 37.03% for Q2 2025, and 45.49% during Q1 2025.